• Citer

Prevalence of lopodystrophy and retinoid syndrome in a 48-week randomized trial to evaluate safety and efficacy of indinavir/ritonavir 800/100 mg versus saquinavir/ritonavir 1000/100 mg: The MaxCmin1 trial

par De Wit, Stéphane ;Wand, H.;Law, Mathew M.G.;Castagna, Antonella;Bruun, Johan N.Johan;Youle, Michael;Vernazza, Pietro;Cassetti, Isabel;Benetucci, Jorge;Dragsted, Ulrik B.Ulrik;Lundgren, Jens D
Référence 9th EACS (October 2003: Warsaw, Poland)
Publication Non publié, 2003

Communication à un colloque

• Détails

Titre:	Prevalence of lopodystrophy and retinoid syndrome in a 48-week randomized trial to evaluate safety and efficacy of indinavir/ritonavir 800/100 mg versus saquinavir/ritonavir 1000/100 mg: The MaxCmin1 trial
Auteur:	De Wit, Stéphane; Wand, H.; Law, Mathew M.G.; Castagna, Antonella; Bruun, Johan N.Johan; Youle, Michael; Vernazza, Pietro; Cassetti, Isabel; Benetucci, Jorge; Dragsted, Ulrik B.Ulrik; Lundgren, Jens D
Informations sur la publication:	9th EACS (October 2003: Warsaw, Poland)
Statut de publication:	Non publié, 2003
Sujet CREF:	Sciences bio-médicales et agricoles
	Pathologie maladies infectieuses
Langue:	Anglais